Decoding autoimmunity.

Research and clinical software for autoimmune disease. Built in Madrid.

Verticals: Health · Research
Science: Molecular mimicry
Data: Processed in the EU¹

Autoimmune disease, in figures.

Autoimmune diseases are common, chronic and costly to treat. Spending on immunology medicines keeps growing, and from 2029 the European Union will have a common legal framework for using health data in research.

1 in 10

people in a UK cohort of 22 million had at least one of 19 autoimmune diseases.²

The Lancet, 2023

+$49 bn

forecast growth in global spending on immunology medicines between 2024 and 2029, an increase of 27 %.³

IQVIA Institute, 2025

2029

the year the European Health Data Space opens the secondary use of health data for research across the EU.⁴

Regulation (EU) 2025/327

Two verticals, on the same science.

Neural Omega works across two verticals: Health, our line in care, and Research, our line in biomedical research. Each defines its own scope, audience and data model.

Vertical 01

Neural Omega Health

Health with independence

The patient's clinical picture and the clinician's practice belong to the people who live them, in a private ecosystem built for preventive and predictive medicine.

Explore Health

Vertical 02

Neural Omega Research

Research within reach

We connect the most advanced research with the people who need it: real-world evidence studies, drug discovery and our own R&D lines.

Explore Research

Products

Each vertical takes shape in its own products, each on its own domain.

One mechanism, four points of view.

Molecular mimicry links what a patient lives, what a clinician reads, what a researcher models and what a therapy may one day target.

PatientLives it.Every day recorded, with consent, can contribute evidence.
ClinicianReads it.Clinical references, at the point of care.
ResearcherModels it.Resemblance between proteins, at proteome scale.
IndustryTargets it.Hypotheses for the earliest stage of discovery.

Read the science

Whether it can be done, and whether it should.

Ethics has its own office at Neural Omega, led by our Chief Purpose Officer, and guides every decision the company makes. Where health data, artificial intelligence or research are at stake, it rests on the four principles of bioethics.

Read our ethics

Autonomy: Data is held in trustPersonal data serves only the purpose it was given for, and the person can see it, take it and withdraw it.
Beneficence: Judgement stays with peopleOur models propose; experimental evidence and professional judgement decide.
Non‑maleficence: We say what we can defendEvery public claim matches its real level of validation.
Justice: We design for everyone affectedRepresentativeness and access count from the first decision.

A Madrid company, with European reach.

Decode itwith us.

Clinicians, researchers, patient organisations, industry and investors: tell us who you are and your message reaches the right person.

Talk to Neural Omega →For investors

Neural Omega processes personal health data in accordance with Regulation (EU) 2016/679 (General Data Protection Regulation), within the European Union.
Conrad N, Misra S, Verbakel JY, et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023;401(10391):1878–1890. doi:10.1016/S0140-6736(23)00457-9
IQVIA Institute for Human Data Science. The Global Use of Medicines 2025: Outlook to 2029 (webinar presentation). June 2025. Global immunology spending in constant US dollars. iqvia.com
Regulation (EU) 2025/327 of the European Parliament and of the Council on the European Health Data Space. Provisions on the secondary use of health data apply from March 2029. eur-lex.europa.eu